Rock Creek Group, LP Cognition Therapeutics Inc Transaction History

Rock Creek Group, LP

  • $1.12 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023
SELL
$1.56 - $3.38 $62,053 - $134,449
-39,778 Reduced 79.56%
10,222 $18,000
Q3 2022

Nov 10, 2022
SELL
$1.63 - $3.6 $48,494 - $107,103
-29,751 Reduced 37.3%
50,000 $95,000
Q2 2022

Aug 08, 2022
BUY
$1.5 - $3.45 $79,968 - $183,926
53,312 Added 201.64%
79,751 $170,000
Q4 2021

Feb 11, 2022
BUY
$5.1 - $12.98 $134,838 - $343,178
26,439 New
26,439 $167,000

Others Institutions Holding CGTX

# of Institutions
45
Shares Held
6.58M
Call Options Held
0
Put Options Held
0
View Full List

About COGNITION THERAPEUTICS INC

CGTX Quotes by TradingView
  • Ticker CGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,710,700
  • Market Cap $13.2M
  • Description
  • Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...
More about CGTX
Track This Portfolio

Track Rock Creek Group, LP Portfolio

Follow Rock Creek Group, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Creek Group, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Creek Group, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email